Table 1.
Demographic of the treatment and placebo groups
| Variable | Levels | Vitex | Placebo | P-value |
|---|---|---|---|---|
| Age (y) | 48–58 | 52.85±2.70 | 52.16±2.80 | 0.38 |
| Occupation | Housekeeper | 23 (88.05) | 24 (92.04) | 0.32 |
| Employed | 3 (11.5) | 2 (7.06) | ||
| Marital status | Single | 2 (7.7) | 2 (7.7) | 0.52 |
| Married | 24 (92.03) | 24 (92.03) | ||
| Income | Less than US$300 monthly income | 12 (46.2) | 18 (69.3) | 0.16 |
| US$300 to 900 monthly income | 12 (46.2) | 8 (30.7) | ||
| More than US$900 monthly income | 2 (7.6) | 0 | ||
| Body mass index (kg/m2) | 1.75–3 | 2.30±0.35 | 2.40±0.25 | 0.17 |
| Years after menopause | 1–3 | 2.02±0.78 | 1.32±0.53 | 0.001** |
| No. of hot flashes | 3–20 | 8.58±5.40 | 9.24±8.40 | 0.74 |
| Menopausal age (y) | 46–57 | 50.94±2.53 | 50.84±2.54 | 0.89 |
| Menarche age (y) | 10–18 | 13.76±1.58 | 13.50±1.69 | 0.58 |
| No. of deliveries | 1–9 | 3.77±1.51 | 3.74±1.76 | 0.95 |
| Adverse effects | Nausea | 3 (11.53) | 1 (3.84) | 0.07 |
| Itching | 2 (7.69) | 0 |
Values are presented as mean±standard deviation or number (%).
**
P<0.01.